基于“肺-肠轴”分析小儿止咳平喘糖浆对痰热阻肺型哮喘患儿免疫炎症及肠道菌群的影响

    Effects of Xiao’er Zhike Pingchuan Syrup on Immune Inflammation and Gut Microbiota in Children with Phlegm Heat Resistance Pulmonary Asthma Based on the “Lung Gut Axis”

    • 摘要:
      目的  基于“肺-肠轴”分析小儿止咳平喘糖浆对痰热阻肺型哮喘患儿免疫炎症及肠道菌群的影响。
      方法 选取2023年1月1日—2024年6月30日就诊的80例急性哮喘患儿,随机数字表法分为中药组40例、安慰剂组40例,中药组在常规治疗(孟鲁司特钠+布地奈德气雾剂)基础上,叠加小儿止咳平喘糖浆治疗,安慰剂组在常规治疗基础上叠加安慰剂糖浆口服。比较2组临床疗效,哮喘控制测试(asthma control test,ACT)问卷、肺功能测定第1秒用力呼气容积(forced expiratory volume in first second in first second,FEV1),用力肺活量(forced vital capacity,FVC),呼气流量峰值(peak expiratory flow,PEF)、免疫细胞含量(Th1、Th2、Treg、Th17、Th22)、血清细胞因子及介质(IFN-γ、IL-4、IL-10、骨膜蛋白、eotaxin、ADAM33);通过16S rRNA基因测序技术分析患者粪便样本中的肠道菌群组成,分析有益菌(如双歧杆菌、乳酸杆菌)和潜在有害菌(如拟杆菌、梭菌属)的变化。采用Pearson分析免疫炎症标志物与肠道菌群结构之间的相关性。
      结果 中药组总有效率 (90.00%) 明显高于安慰剂组 (62.50%)(P<0.01)。治疗后,2组 ACT 评分、FEV1、FEV1/FVC、Th1、Treg、IFN-γ 及有益菌 (双歧杆菌、乳酸杆菌) 丰度均较治疗前显著升高,其中中药组的 ACT 评分、FEV1、FEV1/FVC、Treg、IFN-γ 明显高于安慰剂组(P<0.001),Th1 及有益菌丰度也明显高于安慰剂组(P<0.05);2组 PEF 差异率、Th2、Th17、Th22、IL-4、IL-10、骨膜蛋白、eotaxin、ADAM33 及潜在有害菌 (拟杆菌、梭菌属) 丰度均显著降低,其中中药组的 PEF 差异率、Th17、Th22、IL-4、IL-10、骨膜蛋白、eotaxin、ADAM33 明显低于安慰剂组(P<0.001),Th2 及潜在有害菌丰度也明显低于安慰剂组(P<0.05)。Pearson分析表明,IFN-γ与双歧杆菌、乳酸杆菌呈正相关,与拟杆菌、梭菌属呈负相关(P<0.001);而IL-4、IL-10、骨膜蛋白、eotaxin、ADAM33与拟杆菌、梭菌属呈正相关,与双歧杆菌、乳酸杆菌呈负相关(P<0.001)。
      结论 小儿止咳平喘糖浆治疗痰热阻肺型哮喘患儿临床效果显著,可能通过调节免疫炎症反应及肠道菌群,进而改善临床症状,为哮喘的治疗提供了新的思路。

       

      Abstract:
      OBJECTIVE To investigate the effects of Xiao’er Zhike Pingchuan syrup on immune inflammation and gut microbiota in children with phlegm heat resistant pulmonary asthma based on the “lung gut axis” analysis.
      METHODS Eighty children with acute asthma who came to our hospital for treatment from January 1, 2023 to June 30, 2024 were randomly divided into a traditional Chinese medicine treatment group(TCM group) of 40 cases and a placebo treatment group(placebo group) of 40 cases using a random number table method. The TCM group was treated with Xiao’er Zhike Pingchuan syrup, while the placebo group was treated with placebo syrup orally. Comparing the clinical efficacy of two groups, including asthma control test(ACT) questionnaire, lung functionmeasuring forced expiratory volume in first second(FEV1), forced vital capacity(FVC), peak expiratory flow(PEF), immune cell content(Th1, Th2, Treg, Th17, Th22), serum cytokines and mediators(IFN - γ, IL-4, IL-10, periostin, eotaxin, ADAM33). Analyzing the composition of gut microbiota in patient fecal samples using 16S rRNA gene sequencing technology, and analyzing changes in beneficial bacteria(such as Bifidobacterium and Lactobacillus) and potential harmful bacteria(such as Bacteroides and Clostridium). Pearson analysis was used to investigate the correlation between immune inflammatory markers and gut microbiota structure.
      RESULTS The total effective rate in the TCM group (90.00%) was significantly higher than that in the placebo group(P<0.01). After treatment, the ACT scores, FEV1, FEV1/FVC, Th1, Treg, IFN-γ, and the abundances of beneficial bacteria(Bifidobacterium and Lactobacillus) were significantly increased in both groups; specifically, the ACT scores, FEV1, FEV1/FVC, Treg, and IFN-γ in the TCM group were significantly higher than those in the placebo group(P<0.001), and Th1 and the abundances of beneficial bacteria were also significantly higher than those in the placebo group(P<0.05). The PEF difference rate, Th2, Th17, Th22, IL-4, IL-10, periostin, eotaxin, ADAM33, and the abundances of potential harmful bacteria(Bacteroides and Clostridium) were significantly decreased in both groups; specifically, the PEF difference rate, Th17, Th22, IL-4, IL-10, periostin, eotaxin, and ADAM33 in the TCM group were significantly lower than those in the placebo group(P<0.001), and Th2 and the abundances of potential harmful bacteria were also significantly lower than those in the placebo group(P<0.05). Pearson analysis showed that IFN-γ was positively correlated with Bifidobacterium and Lactobacillus, and negatively correlated with Bacteroides and Clostridium(P<0.05). IL-4, IL-10, periostin, eotaxin, and ADAM33 were positively correlated with Bacteroides and Clostridium, and negatively correlated with Bifidobacterium and Lactobacillus(P<0.001).
      CONCLUSION The clinical effect of Xiao’er Zhike Pingchuan syrup in treating children with phlegm heat resistance pulmonary asthma is significant. It may improve clinical symptoms by regulating immune inflammatory response and gut microbiota, providing new ideas for the treatment of asthma.

       

    /

    返回文章
    返回